Hepatitis C virus treatment is often restricted in Medicaid patients. This analysis evaluates the clinical and cost impacts of treating all Medicaid patients versus the current status quo.
Rachel Beckerman, PhD
Advertisement
Articles by Rachel Beckerman, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on AJMC
1
Unanswered Questions in First- and Second-Line mCRC Care
2
First-Line Vitiligo Treatment: Topical JAK Inhibitors and Phototherapy
3
Precision Drugs Meet Payer Realities
4
Cleveland Clinicians Say Obesity Care Starts Too Late for Many Patients
5